Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?

To: Burlitis who wrote (361)	3/20/1998 12:51:00 AM
From: HeyRainier	Respond to of 1720

[ Trinity Biotech: TRIBY ] Alex, Yes, I did purchase TRIBY today...at 2 1/32 after a number of factors became evident about the company's fundamental and technical characteristics. Making 30%+ in a day for a single issue is quite unusual for me, and even then, with my leveraged position in this (don't ask, but that explains the "Soros" part of my profile), you can see why my portfolio & I are quite happy with all of this. Today's trade was a combination of luck being met with preparation. It was an attractive entry based on the risk/reward characteristics of the stock. The ultra-support combined with a long term breakout, and the management alignment of shareholder interests were all contributing factors, plus Scott Davis' invaluable comments about the company's fundamentals (add to that the very knowledgeable sources at the TRIBY thread~~you know who you are). To them: Thank you. Also, I did not know the 56ers were hounding this one too. I don't read them, but good for them; it's amazing what happens sometimes when two sources that act independently of each other both reach the same conclusion about a particular stock. Maybe we'll strike gold again in the future. Regards, Rainier